StockVS

Stepan Company (SCL) Stock Analysis

Basic Materials

Stepan Company

$53.20

+$1.13 (+2.17%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Stepan Company functions as a manufacturer and distributor of specialty and intermediate chemicals, supplying these materials to other manufacturers for integration into various end products across the United States, France, Poland, the United Kingdom, Brazil, Mexico, and international markets. Operating within the Basic Materials sector and the Specialty Chemicals industry, the company provides essential chemical components that are critical for the production cycles of diverse downstream industries. The organization employs a workforce of 2,328 individuals and maintains a total market capitalization of $1.12 billion, reflecting its established presence in the global chemical supply chain. With annual revenue reaching $2.33 billion, these financial figures indicate that the company operates at a significant scale, positioning it as a substantial player capable of leveraging its distribution network across multiple geographic regions.

Financial Health

The company reported total revenue of $2.33 billion over the trailing twelve months, with a corresponding net income of $46.90 million and an EBITDA of $194.90 million. The substantial gap between the $2.33 billion in revenue and the $46.90 million in net income reveals a cost structure characterized by significant operating expenses and overhead costs that consume the majority of gross receipts before reaching the bottom line. Free cash flow stands at $10.20 million, which indicates the company's ability to generate cash after capital expenditures, though the relatively low figure suggests tight liquidity management or specific capital investment requirements. The gross margin is reported at 11.6%, indicating that the company retains a modest portion of revenue after direct production costs, while the operating margin is listed as 0.0%, signaling that operating expenses largely offset gross profit before interest and taxes. The profit margin sits at 2.0%, further illustrating the thin profitability layer remaining after all operational costs are deducted. On the balance sheet, the company holds $132.69 million in cash against total debt of $691.04 million, resulting in a debt-to-equity ratio of 55.55, which characterizes the firm as a leveraged entity rather than one with a conservative, debt-free stance. The current ratio is 1.29, a metric that indicates the company possesses sufficient current assets to cover its short-term liabilities with a ratio slightly above one. Return on equity is 3.9% and return on assets is 1.8%, metrics that reveal management effectiveness in generating returns relative to shareholder equity and total asset base, respectively, though these percentages suggest a capital-intensive environment where returns are moderated by high asset and debt levels.

Valuation Assessment

The stock trades at a trailing P/E ratio of 24.14 while the forward P/E is 11.87, a significant disparity that implies the market expects a substantial increase in earnings in the future to justify the current high valuation multiple. The price-to-book ratio is 0.90, which indicates that the market values the company at roughly equal to or slightly below its book value, suggesting no significant market premium over the net asset value recorded on the balance sheet. Alternative valuation metrics include a price-to-sales ratio of 0.48 and an EV/EBITDA of 8.61, figures that suggest the company is priced conservatively relative to its sales volume and enterprise earnings power. The 52-week high is $68.00 and the 52-week low is $41.82, providing a trading range within which the current share price fluctuates based on market sentiment and liquidity. The beta value is 1.04, which means the stock's price volatility is slightly higher than the broader market, moving 4% more than the benchmark index on average during periods of market fluctuation.

Growth & Income

Revenue growth over the last year is 5.4%, while earnings growth is 49.1%, indicating that earnings are expanding at a rate significantly faster than revenue, which often implies improving operational efficiency or a shift toward higher-margin product mixes. As a dividend payer, the company offers a dividend yield of 3.2% with a payout ratio of 75.6%, a ratio that must be monitored closely to ensure sustainability given the thin profit margins and the fact that earnings growth currently outpaces revenue growth. The high payout ratio relative to the thin profit margins suggests that the dividend is supported by the strong earnings growth but leaves little room for error if earnings were to stagnate. Overall, the growth and income profile presents a scenario where the company delivers moderate revenue expansion paired with aggressive earnings growth and a substantial current yield, balancing income generation with capital appreciation potential.

Peer Comparison

Stepan Company (SCL) operates in the Specialty Chemicals industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Stepan Company SCL $1.21B N/A
Linde plc LIN $238.09B 34.1
The Sherwin-Williams Company SHW $76.77B 29.9
Ecolab Inc. ECL $71.55B 34.4

The Specialty Chemicals industry average P/E ratio is 54.8x. Stepan Company trades at a P/E of N/A.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Stepan Company

Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, lubricating ingredients; emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites. The Polymers segment provides polyurethane polyols that are used in the manufacture of rigid foam for thermal insulation in the construction industry, as well as a base raw material for coatings, adhesives, sealants, and elastomers (CASE); polyester resins used in coating applications; specialty polyols, such as CASE and powdered polyester resins; and phthalic anhydride that is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. The Specialty Products segment offers flavors, emulsifiers, and solubilizers for use in food, flavoring, nutritional supplement, and pharmaceutical applications. Stepan Company was founded in 1932 and is headquartered in Northbrook, Illinois.

Visit website →

Key Statistics

Market Cap
$1.21B
P/E Ratio
N/A
52-Week High
$68.00
52-Week Low
$41.82
Avg Volume
150.41K
Beta
0.95
Dividend Yield
2.97%

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
United States
Employees
2,328